We are live on
!
Find out more
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
0 hedge funds and large institutions have $0 invested in Intercept Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 146 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 146 → 0 (-146)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $725M → $0 (-$725M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 146
Holders
–
Holders Change
-146
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
146
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
BlackRock
New York
|
-$78.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$59.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$55.6M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$44.6M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$40.8M |
